SEC Filing Details
Nov 24, 2020
Nov 23, 2020
Amendment to a previously filed 8-K
KemPharm® is a clinical stage, specialty pharmaceutical company engaged in the development and discovery of proprietary prodrugs that are designed to be improved versions of widely prescribed and FDA approved products.